Convergent Evolution Dynamics of SARS-CoV-2 and HIV Surface Envelope Glycoproteins Driven by Host Cell Surface Receptors and Lipid Rafts: Lessons for the Future

Int J Mol Sci. 2023 Jan 18;24(3):1923. doi: 10.3390/ijms24031923.

Abstract

Although very different, in terms of their genomic organization, their enzymatic proteins, and their structural proteins, HIV and SARS-CoV-2 have an extraordinary evolutionary potential in common. Faced with various selection pressures that may be generated by treatments or immune responses, these RNA viruses demonstrate very high adaptive capacities, which result in the continuous emergence of variants and quasi-species. In this retrospective analysis of viral proteins, ensuring the adhesion of these viruses to the plasma membrane of host cells, we highlight many common points that suggest the convergent mechanisms of evolution. HIV and SARS-CoV-2 first recognize a lipid raft microdomain that acts as a landing strip for viral particles on the host cell surface. In the case of mucosal cells, which are the primary targets of both viruses, these microdomains are enriched in anionic glycolipids (gangliosides) forming a global electronegative field. Both viruses use lipid rafts to surf on the cell surface in search of a protein receptor able to trigger the fusion process. This implies that viral envelope proteins are both geometrically and electrically compatible to the biomolecules they select to invade host cells. In the present study, we identify the surface electrostatic potential as a critical parameter controlling the convergent evolution dynamics of HIV-1 and SARS-CoV-2 surface envelope proteins, and we discuss the impact of this parameter on the phenotypic properties of both viruses. The virological data accumulated since the emergence of HIV in the early 1980s should help us to face present and future virus pandemics.

Keywords: HIV-1; SARS-CoV-2; electrostatic surface potential; ganglioside; lipid raft; quasi-species; receptor; virus evolution.

Publication types

  • Review

MeSH terms

  • Antigens, Viral / metabolism
  • COVID-19* / metabolism
  • Glycoproteins / metabolism
  • HIV Infections* / metabolism
  • Humans
  • Membrane Microdomains / metabolism
  • Receptors, Cell Surface / metabolism
  • Retrospective Studies
  • SARS-CoV-2
  • Viral Proteins / metabolism

Substances

  • Viral Proteins
  • Receptors, Cell Surface
  • Antigens, Viral
  • Glycoproteins

Grants and funding

This research received no external funding.